Redefining space pharmacology: bridging knowledge gaps in drug efficacy and safety for deep space missions
The space environment is incredibly hostile, and humans are vulnerable in such conditions. Astronauts encounter various stress factors during a space journey, including radiation, microgravity, forceful acceleration during launch, altered magnetic fields, and confinement. These stressors significant...
Saved in:
| Published in: | Frontiers in space technologies Vol. 5 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Frontiers Media S.A
18.10.2024
|
| Subjects: | |
| ISSN: | 2673-5075, 2673-5075 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | The space environment is incredibly hostile, and humans are vulnerable in such conditions. Astronauts encounter various stress factors during a space journey, including radiation, microgravity, forceful acceleration during launch, altered magnetic fields, and confinement. These stressors significantly impact the human body homeostasis, leading to physio-pathological adaptations, loss of bone density, muscle atrophy, cardiovascular deconditioning, alterations in liver function, vestibular adaptations, and immune system dysregulation. These alterations can potentially influence drug pharmacokinetics and pharmacodynamics, affecting the efficacy and safety of medications administered to astronauts. Due to the limited number of studies on pharmaceuticals conducted in microgravity conditions, it’s challenging to assess the effectiveness and stability of these medications during spaceflight. The objective of the present work is to compare the state-of-the-art knowledge on PK/PD changes and factors likely to affect them during spaceflight, with the subjective perception of the problem by a collection of separate interviews conducted with seven experts in the field. The interviewees were chosen as “experts,” i.e., representatives in a specific discipline, who possess knowledge and experience in space pharmacology, physiology, or biology. Thus, our panel included astronauts, space surgeons, and scientists aiming to bridge the lack of experimental data in the literature. Each interview explores assorted aspects of space physiology and pharmacology, including drug use and storage onboard the ISS; notable consideration has arisen regarding the current research gaps and future space expeditions. All the interviews were held remotely using online conferencing software. None of the interviewees could provide a comprehensive overview regarding potential changes in drugs PK/PD in microgravity conditions. Further, any medication brought on board (whether as part of an astronaut’s medical kit or stored in the ISS pharmacy) is destroyed, thereby suppressing the possibility of analyzing any degradation products resulting from long-term exposure to microgravity and radiation. According to these results, the use of drugs without understanding how they are genuinely absorbed, distributed, metabolized, and excreted in microgravity conditions is concerning, posing risks for drug effectiveness. Conducting genotyping and phenotyping on astronauts would be beneficial for developing personalized pharmacological countermeasures for each astronaut and anticipating expected drug metabolism changes during space missions. |
|---|---|
| AbstractList | The space environment is incredibly hostile, and humans are vulnerable in such conditions. Astronauts encounter various stress factors during a space journey, including radiation, microgravity, forceful acceleration during launch, altered magnetic fields, and confinement. These stressors significantly impact the human body homeostasis, leading to physio-pathological adaptations, loss of bone density, muscle atrophy, cardiovascular deconditioning, alterations in liver function, vestibular adaptations, and immune system dysregulation. These alterations can potentially influence drug pharmacokinetics and pharmacodynamics, affecting the efficacy and safety of medications administered to astronauts. Due to the limited number of studies on pharmaceuticals conducted in microgravity conditions, it’s challenging to assess the effectiveness and stability of these medications during spaceflight. The objective of the present work is to compare the state-of-the-art knowledge on PK/PD changes and factors likely to affect them during spaceflight, with the subjective perception of the problem by a collection of separate interviews conducted with seven experts in the field. The interviewees were chosen as “experts,” i.e., representatives in a specific discipline, who possess knowledge and experience in space pharmacology, physiology, or biology. Thus, our panel included astronauts, space surgeons, and scientists aiming to bridge the lack of experimental data in the literature. Each interview explores assorted aspects of space physiology and pharmacology, including drug use and storage onboard the ISS; notable consideration has arisen regarding the current research gaps and future space expeditions. All the interviews were held remotely using online conferencing software. None of the interviewees could provide a comprehensive overview regarding potential changes in drugs PK/PD in microgravity conditions. Further, any medication brought on board (whether as part of an astronaut’s medical kit or stored in the ISS pharmacy) is destroyed, thereby suppressing the possibility of analyzing any degradation products resulting from long-term exposure to microgravity and radiation. According to these results, the use of drugs without understanding how they are genuinely absorbed, distributed, metabolized, and excreted in microgravity conditions is concerning, posing risks for drug effectiveness. Conducting genotyping and phenotyping on astronauts would be beneficial for developing personalized pharmacological countermeasures for each astronaut and anticipating expected drug metabolism changes during space missions. |
| Author | Barchetti, Karen Derobertmasure, Audrey Sestili, Piero Boutouyrie, Pierre |
| Author_xml | – sequence: 1 givenname: Karen surname: Barchetti fullname: Barchetti, Karen – sequence: 2 givenname: Audrey surname: Derobertmasure fullname: Derobertmasure, Audrey – sequence: 3 givenname: Pierre surname: Boutouyrie fullname: Boutouyrie, Pierre – sequence: 4 givenname: Piero surname: Sestili fullname: Sestili, Piero |
| BookMark | eNp9kMtKBDEQRYMo-PwBV_mBGfNO2p2ILxAE0XWozqPN2NNpkhaZv3dmHERcuKqibt2zOMdof8hDQOickjnnprmIpY7TnBEm5lRIpajYQ0dMaT6TRMv9X_shOqt1QQhhRmpO9BFaPAcfYhrS0OE6ggt4fIOyBJf73K0ucVuS7zbh-5A_--C7gDsYK04D9uWjwyHG5MCtMAweV4hhWuGYC_YhjDvgMtWa8lBP0UGEvoaz3TxBr7c3L9f3s8enu4frq8eZY0ZPM8cDd200RrVRaWNAeA-0bRtwQhlhHKFRKhZ84wxjXgnnQGrdMLN-aBznJ-jhm-szLOxY0hLKymZIdnvIpbNQpuT6YFvaai4jk8Rz4QkYLUWkPAILlElF1yz2zXIl11pC_OFRYjfy7Va-3ci3O_nrkvlTcmmCae1gKpD6_6pfW_OPCg |
| CitedBy_id | crossref_primary_10_3389_frspt_2025_1553854 crossref_primary_10_24304_kjcp_2025_35_2_75 |
| Cites_doi | 10.1208/s12248-015-9834-5 10.1002/j.1552-4604.1995.tb04110.x 10.3357/amhp.5392.2020 10.1016/j.jchromb.2022.123539 10.1515/dmpt-2021-0159 10.1208/s12248-011-9270-0 10.3390/biomedicines10010059 10.1038/s41526-019-0076-1 10.1152/ajpheart.00802.2015 10.1007/s11094-009-0255-6 10.1038/s41598-019-46303-8 10.1038/scientificamerican0998-58 10.1038/s41526-023-00262-7 10.1080/17425255.2020.1746763 10.1096/fj.14-264838 10.1016/s1474-4422(14)70122-x 10.1007/s00198-012-2243-z 10.3389/fphys.2017.00547 10.1016/j.jpba.2016.12.040 10.3389/fphys.2023.1281327 10.1038/srep29901 10.3390/life12040495 10.1016/j.jacc.2018.05.079 10.1016/j.lssr.2016.09.001 10.1001/jamaophthalmol.2020.0673 10.22541/au.172498722.28068605/v1 10.1097/00005768-199608000-00007 10.1177/0091270005276620 10.1177/0091270006291032 10.3389/fphys.2020.553929 10.1007/s00018-021-04025-z 10.1016/j.ijpx.2022.100121 10.1016/s0891-5849(97)00278-5 10.1109/AERO50100.2021.9438263 10.1038/s41526-019-0075-2 10.1021/acsmedchemlett.1c00681 10.1038/s41526-020-0097-9 10.1177/0091270003257229 10.1007/s11095-019-2679-3 10.3389/fbioe.2021.739747 10.1016/j.patter.2022.100550 10.1111/bph.15822 10.1016/j.ejps.2017.05.025 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION DOA |
| DOI | 10.3389/frspt.2024.1456614 |
| DatabaseName | CrossRef DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Astronomy & Astrophysics |
| EISSN | 2673-5075 |
| ExternalDocumentID | oai_doaj_org_article_b1b735f250d34d0a8754f13fa2e12561 10_3389_frspt_2024_1456614 |
| GroupedDBID | 9T4 AAFWJ AAYXX AFPKN ALMA_UNASSIGNED_HOLDINGS ARCSS CITATION GROUPED_DOAJ M~E OK1 |
| ID | FETCH-LOGICAL-c287t-c3e3cbf886bf6788a4dda1bb9ac46848c01f562ed9c822d64cca577928ac49c33 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 4 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001345753600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2673-5075 |
| IngestDate | Fri Oct 03 12:52:07 EDT 2025 Sat Nov 29 03:04:37 EST 2025 Tue Nov 18 21:21:49 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c287t-c3e3cbf886bf6788a4dda1bb9ac46848c01f562ed9c822d64cca577928ac49c33 |
| OpenAccessLink | https://doaj.org/article/b1b735f250d34d0a8754f13fa2e12561 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_b1b735f250d34d0a8754f13fa2e12561 crossref_primary_10_3389_frspt_2024_1456614 crossref_citationtrail_10_3389_frspt_2024_1456614 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-10-18 |
| PublicationDateYYYYMMDD | 2024-10-18 |
| PublicationDate_xml | – month: 10 year: 2024 text: 2024-10-18 day: 18 |
| PublicationDecade | 2020 |
| PublicationTitle | Frontiers in space technologies |
| PublicationYear | 2024 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | B20 Barravecchia (B5) 2022; 79 Fogtman (B23) 2023; 9 Wotring (B52) 2011 Cerri (B9) 2016; 11 Cintrón (B11) Ax (B1) 2023; 14 Lee (B34) 2020; 6 Barchetti (B3) 2024 Derobertmasure (B18) 2023; 1219 Southard (B44) 2024 Thuro (B46) 2021 Saivin (B41) 1995; 35 Tran (B47) 2022; 13 Wotring (B54) 2016; 18 Hargens (B27) 1996; 28 Mehta (B37) 2017; 136 Eyal (B21) 2020; 16 Hughson (B29) 2016; 310 B8 Lemke (B35) 2013 Cope (B12) 2022; 3 Demontis (B15) 2017; 8 Gandia (B26) 2006; 46 LeBlanc (B32) 2013; 24 Kovachevich (B31) 2009; 43 Wotring (B53) 2015; 29 Polyakov (B39) 2022; 37 White (B51) 1998; 279 Barger (B4) 2014; 13 Gandia (B25) 2003; 43 Blue (B7); 5 Voorhies (B50) 2019; 9 Hollander (B28) 1998; 24 Eyal (B22) 2019; 36 Du (B19) 2011; 13 Macias (B36) 2020; 138 Derobertmasure (B17) 2024 Pavez (B38) 2021; 9 Blue (B6); 5 Turroni (B48) 2020; 11 LeBlanc (B33) 2002; 2 Rang (B40) 2016 Kast (B30) 2017; 109 Schuck (B42) 2005; 45 Seoane-Viaño (B43) 2022; 4 Cintrón (B10) Tesei (B45) 2022; 12 Baran (B2) 2021; 10 VirginiaE (B49) 2020; 91 Freeman (B24) 2018; 72 Delp (B14) 2016; 6 Dello (B13) 2022; 179 |
| References_xml | – volume: 18 start-page: 210 year: 2016 ident: B54 article-title: Chemical potency and degradation products of medications stored over 550 Earth days at the international space station publication-title: AAPS J. doi: 10.1208/s12248-015-9834-5 – volume: 35 start-page: 697 year: 1995 ident: B41 article-title: Impact of a four‐day head‐down tilt (–6°) on lidocaine pharmacokinetics used as probe to evaluate hepatic blood flow publication-title: J. Clin. Pharmacol. doi: 10.1002/j.1552-4604.1995.tb04110.x – volume-title: StatPearls year: 2024 ident: B44 article-title: Promethazine – volume: 91 start-page: 41 year: 2020 ident: B49 article-title: Dose tracker application for collecting medication use data from international space station crew publication-title: Aerosp. Med. Hum. Perform. doi: 10.3357/amhp.5392.2020 – volume: 1219 start-page: 123539 year: 2023 ident: B18 article-title: Dried Urine Spot Analysis for assessing cardiovascular drugs exposure applicable in spaceflight conditions publication-title: J. Chromatogr. B doi: 10.1016/j.jchromb.2022.123539 – volume-title: RANG and DALE farmacologia ottava edizione year: 2016 ident: B40 – volume: 37 start-page: 163 year: 2022 ident: B39 article-title: Study of the pharmacokinetics of various drugs under conditions of antiorthostatic hypokinesia and the pharmacokinetics of acetaminophen under long-term spaceflight conditions publication-title: Drug Metab. Pers. Ther. doi: 10.1515/dmpt-2021-0159 – volume: 13 start-page: 299 year: 2011 ident: B19 article-title: Evaluation of physical and chemical changes in pharmaceuticals flown on space missions publication-title: AAPS J. doi: 10.1208/s12248-011-9270-0 – volume: 10 start-page: 59 year: 2021 ident: B2 article-title: The cardiovascular system in space: focus on in vivo and in vitro studies publication-title: Biomedicines doi: 10.3390/biomedicines10010059 – volume: 5 start-page: 15 ident: B7 article-title: Limitations in predicting radiation-induced pharmaceutical instability during long-duration spaceflight publication-title: Npj Microgravity doi: 10.1038/s41526-019-0076-1 – volume: 310 start-page: H628 year: 2016 ident: B29 article-title: Increased postflight carotid artery stiffness and inflight insulin resistance resulting from 6-mo spaceflight in male and female astronauts publication-title: Am. J. Physiol-Heart Circ. Physiol. doi: 10.1152/ajpheart.00802.2015 – volume: 43 start-page: 130 year: 2009 ident: B31 article-title: Pharmacokinetics of acetaminophen administered in tablets and capsules under long-term space flight conditions publication-title: Pharm. Chem. J. doi: 10.1007/s11094-009-0255-6 – volume: 9 start-page: 9911 year: 2019 ident: B50 article-title: Study of the impact of long-duration space missions at the International Space Station on the astronaut microbiome publication-title: Sci. Rep. doi: 10.1038/s41598-019-46303-8 – volume: 279 start-page: 58 year: 1998 ident: B51 article-title: Weightlessness and the human body publication-title: Sci. Am. doi: 10.1038/scientificamerican0998-58 – volume: 9 start-page: 8 year: 2023 ident: B23 article-title: Towards sustainable human space exploration—priorities for radiation research to quantify and mitigate radiation risks publication-title: Npj Microgravity. doi: 10.1038/s41526-023-00262-7 – volume: 16 start-page: 353 year: 2020 ident: B21 article-title: How do the pharmacokinetics of drugs change in astronauts in space? publication-title: Expert Opin. Drug Metab. Toxicol. doi: 10.1080/17425255.2020.1746763 – start-page: 25 volume-title: Results of the life science DSOs conducted aboard the space shuttle 1981–1986 ident: B11 article-title: Inflight salivary pharmacokinetics of scopolamine and dextroamphetamine – volume: 29 start-page: 4417 year: 2015 ident: B53 article-title: Medication use by U.S. Crewmembers on the international space station publication-title: FASEB J. doi: 10.1096/fj.14-264838 – volume: 13 start-page: 904 year: 2014 ident: B4 article-title: Prevalence of sleep deficiency and use of hypnotic drugs in astronauts before, during, and after spaceflight: an observational study publication-title: Lancet Neurol. doi: 10.1016/s1474-4422(14)70122-x – volume: 24 start-page: 2105 year: 2013 ident: B32 article-title: Bisphosphonates as a supplement to exercise to protect bone during long-duration spaceflight publication-title: Osteoporos. Int. doi: 10.1007/s00198-012-2243-z – volume: 8 start-page: 547 year: 2017 ident: B15 article-title: Human pathophysiological adaptations to the space environment publication-title: Front. Physiol. doi: 10.3389/fphys.2017.00547 – volume-title: Foye’s Principles of medicinal chemistry year: 2013 ident: B35 – volume: 136 start-page: 111 year: 2017 ident: B37 article-title: Impact of space environment on stability of medicines: challenges and prospects publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2016.12.040 – volume: 14 start-page: 1281327 year: 2023 ident: B1 article-title: Dry eye disease in astronauts: a narrative review publication-title: Front. Physiol. doi: 10.3389/fphys.2023.1281327 – volume: 2 start-page: 335 year: 2002 ident: B33 article-title: Alendronate as an effective countermeasure to disuse induced bone loss publication-title: J. Musculoskelet. Neuronal Interact. – volume: 6 start-page: 29901 year: 2016 ident: B14 article-title: Apollo lunar astronauts show higher cardiovascular disease mortality: possible deep space radiation effects on the vascular endothelium publication-title: Sci. Rep. doi: 10.1038/srep29901 – volume: 12 start-page: 495 year: 2022 ident: B45 article-title: Understanding the complexities and changes of the astronaut microbiome for successful long-duration space missions publication-title: Life doi: 10.3390/life12040495 – volume: 72 start-page: 1294 year: 2018 ident: B24 article-title: Orthostatic hypotension publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2018.05.079 – volume: 11 start-page: 1 year: 2016 ident: B9 article-title: Hibernation for space travel: impact on radioprotection publication-title: Life Sci. Space Res. doi: 10.1016/j.lssr.2016.09.001 – volume: 138 start-page: 553 year: 2020 ident: B36 article-title: Association of long-duration spaceflight with anterior and posterior ocular structure changes in astronauts and their recovery publication-title: JAMA Ophthalmol. doi: 10.1001/jamaophthalmol.2020.0673 – ident: B20 – year: 2024 ident: B17 article-title: Feasibility of dried blood spot collection for caffeine pharmacokinetic studies in microgravity: insights from parabolic flight campaigns publication-title: Br. J. Clin. Pharmacol. under review doi: 10.22541/au.172498722.28068605/v1 – volume-title: Space travels, astronauts, and drugs the state of the art on pharmacological aspects through interview analysis with experts in the field year: 2024 ident: B3 – volume: 28 start-page: 977 year: 1996 ident: B27 article-title: Cardiovascular adaptation to spaceflight publication-title: Med. Sci. Sports Exerc doi: 10.1097/00005768-199608000-00007 – volume: 45 start-page: 822 year: 2005 ident: B42 article-title: Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers publication-title: J. Clin. Pharmacol. doi: 10.1177/0091270005276620 – volume: 46 start-page: 1008 year: 2006 ident: B26 article-title: Influence of simulated weightlessness on the intramuscular and oral pharmacokinetics of promethazine in 12 human volunteers publication-title: J. Clin. Pharmacol. doi: 10.1177/0091270006291032 – volume: 11 start-page: 553929 year: 2020 ident: B48 article-title: Gut microbiome and space travelers’ health: state of the art and possible pro/prebiotic strategies for long-term space missions publication-title: Front. Physiol. doi: 10.3389/fphys.2020.553929 – volume: 79 start-page: 28 year: 2022 ident: B5 article-title: Microgravity and space radiation inhibit autophagy in human capillary endothelial cells, through either opposite or synergistic effects on specific molecular pathways publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-021-04025-z – volume-title: Evidence report: risk of therapeutic failure due to ineffectiveness of medication year: 2011 ident: B52 – volume: 4 start-page: 100121 year: 2022 ident: B43 article-title: To infinity and beyond: strategies for fabricating medicines in outer space publication-title: Int. J. Pharm. X doi: 10.1016/j.ijpx.2022.100121 – volume: 24 start-page: 385 year: 1998 ident: B28 article-title: Spaceflight downregulates antioxidant defense systems in rat liver publication-title: Free Radic. Biol. Med. doi: 10.1016/s0891-5849(97)00278-5 – ident: B8 – start-page: 1 volume-title: 2021 IEEE aerospace conference (50100). Big sky year: 2021 ident: B46 article-title: Characterization of the Apollo astronaut lunar extravehicular activity falls and near-falls doi: 10.1109/AERO50100.2021.9438263 – volume: 5 start-page: 14 ident: B6 article-title: Supplying a pharmacy for NASA exploration spaceflight: challenges and current understanding publication-title: Npj Microgravity doi: 10.1038/s41526-019-0075-2 – volume: 13 start-page: 1231 year: 2022 ident: B47 article-title: Space medicines for space health publication-title: ACS Med. Chem. Lett. doi: 10.1021/acsmedchemlett.1c00681 – volume: 6 start-page: 7 year: 2020 ident: B34 article-title: Spaceflight associated neuro-ocular syndrome (SANS) and the neuro-ophthalmologic effects of microgravity: a review and an update publication-title: Npj Microgravity doi: 10.1038/s41526-020-0097-9 – volume: 43 start-page: 1235 year: 2003 ident: B25 article-title: Influence of simulated weightlessness on the oral pharmacokinetics of acetaminophen as a gastric emptying probe in man: a plasma and a saliva study publication-title: J. Clin. Pharmacol. doi: 10.1177/0091270003257229 – volume: 36 start-page: 148 year: 2019 ident: B22 article-title: Medications in space: in search of a pharmacologist’s guide to the galaxy publication-title: Pharm. Res. doi: 10.1007/s11095-019-2679-3 – volume: 9 start-page: 739747 year: 2021 ident: B38 article-title: The future of personalized medicine in space: from observations to countermeasures publication-title: Front. Bioeng. Biotechnol. doi: 10.3389/fbioe.2021.739747 – start-page: 19 volume-title: Results of the life science DSOs conducted aboard the space shuttle 1981–1986 ident: B10 article-title: Inflight pharmacokinetics of acetaminophen in saliva – volume: 3 start-page: 100550 year: 2022 ident: B12 article-title: Routine omics collection is a golden opportunity for European human research in space and analog environments publication-title: Patterns doi: 10.1016/j.patter.2022.100550 – volume: 179 start-page: 2538 year: 2022 ident: B13 article-title: Physiological adaptations affecting drug pharmacokinetics in space: what do we really know? A critical review of the literature publication-title: Br. J. Pharmacol. doi: 10.1111/bph.15822 – volume: 109 start-page: S2 year: 2017 ident: B30 article-title: Drugs in space: pharmacokinetics and pharmacodynamics in astronauts publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2017.05.025 |
| SSID | ssj0002857307 |
| Score | 2.2983687 |
| Snippet | The space environment is incredibly hostile, and humans are vulnerable in such conditions. Astronauts encounter various stress factors during a space journey,... |
| SourceID | doaj crossref |
| SourceType | Open Website Enrichment Source Index Database |
| SubjectTerms | astronauts metabolism microgravity pharmacodynamics pharmacokinetics space environment |
| Title | Redefining space pharmacology: bridging knowledge gaps in drug efficacy and safety for deep space missions |
| URI | https://doaj.org/article/b1b735f250d34d0a8754f13fa2e12561 |
| Volume | 5 |
| WOSCitedRecordID | wos001345753600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2673-5075 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002857307 issn: 2673-5075 databaseCode: DOA dateStart: 20210101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2673-5075 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002857307 issn: 2673-5075 databaseCode: M~E dateStart: 20200101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PS8MwFA4iHryIP9n8RQ7iRcrWJm0Sb1M2POgQUditpMnL2NBurJuwi3-7L22d86IXL6U0aQgvj3zveyTfI-RCWJs4o3jgb8oEPMriIONtHigegTKhEFCp69-Lfl8OBupxrdSXPxNWyQNXhmtlYSZY7BCpLeO2rTG-5i5kTkeA2FwRH4x61sjUuEwZxei6orolgyxMtRzSRH92MuK4OcQelX4g0Zpgf4ksvV2yU4eEtFNNZY9sQL5PGp3CJ6knb0t6Scv3KgdRHJDxE1hwZWEHivuBATr91p9eXtPyDpZvXOXL6FBPCzrKqZ0thhS8aoQ2S6pzSwvtYL6kGLpSCzCtB8TF91m04pC89LrPt3dBXTIhMEh95oFhwEzmpEwyhzAkNbdWh1mmtOGJ5NK0Q4cRD1hlMDKwCccFjIVQkcQOyjB2RDbzSQ4N4idjkdvIEBLFE93WwAWTwgHTAmRkmiT8Ml9qaj1xX9biNUVe4U2eliZPvcnT2uRNcrX6Z1qpafza-8avyqqnV8IuP6B_pLV_pH_5x_F_DHJCtv3EPGaF8pRszmcLOCNb5n0-Kmbnpevh8-Gj-wliTOAm |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Redefining+space+pharmacology%3A+bridging+knowledge+gaps+in+drug+efficacy+and+safety+for+deep+space+missions&rft.jtitle=Frontiers+in+space+technologies&rft.au=Karen+Barchetti&rft.au=Karen+Barchetti&rft.au=Karen+Barchetti&rft.au=Audrey+Derobertmasure&rft.date=2024-10-18&rft.pub=Frontiers+Media+S.A&rft.eissn=2673-5075&rft.volume=5&rft_id=info:doi/10.3389%2Ffrspt.2024.1456614&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b1b735f250d34d0a8754f13fa2e12561 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2673-5075&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2673-5075&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2673-5075&client=summon |